An approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head-and-neck cancer

Medical Physics

Volumn 39, Issue 8, 2012, Pages 5277-5285

  Wang, Peng ^a   Popovtzer, Aron ^a   Eisbruch, Avraham ^a   Cao, Yue ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

blood volume; DCE MRI; functional imaging biomarker; head and neck cancers

Indexed keywords

BLOOD; DISEASES; FORECASTING; HEMODYNAMICS; MAGNETIC RESONANCE IMAGING; TUMORS;

BLOOD VOLUMES; CHEMORADIATION THERAPIES; DCE-MRI; DYNAMIC CONTRAST ENHANCED MRIS (DCE); FUNCTIONAL IMAGING; HEAD-AND-NECK CANCER; HETEROGENEOUS DISTRIBUTIONS; RECEIVER OPERATING CHARACTERISTIC ANALYSIS;

PATIENT TREATMENT;

EID: 84864722055     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.4737022     Document Type: Article

References (55)

1. D. J. Lee, Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas., Int. J. Radiat. Oncol. Biol. Phys. 32, 567-576 (1995). 10.1016/0360-3016(95)00150-W
2. R. J. Bensadoun, M. C. Etienne, O. Dassonville, P. Chauvel, X. Pivot, P. Y. Marcy, B. Prevost, B. Coche-Dequeant, S. Bourdin, J. Vallicioni, G. Poissonnet, A. Courdi, E. Teissier, J. L. Lagrange, A. Thyss, J. Santini, F. Demard, M. Schneider, and G. Milano, Concomitant b.i.d. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: Clinical and pharmacological data of a French multicenter phase II study., Int. J. Radiat. Oncol. Biol. Phys. 42, 237-245 (1998). 10.1016/S0360-3016(98)00235-1 (Pubitemid 28502768)
3. J. Bernier, H. D. Thames, C. D. Smith, and J. C. Horiot, Tumor response, mucosal reactions and late effects after conventional and hyperfractionated radiotherapy., Radiother. Oncol. 47, 137-143 (1998). 10.1016/S0167-8140(97) 00221-1 (Pubitemid 28275922)
4. F. Denis, P. Garaud, E. Bardet, M. Alfonsi, C. Sire, T. Germain, P. Bergerot, B. Rhein, J. Tortochaux, P. Oudinot, and G. Calais, Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: Comparison of LENTSOMA, RTOGEORTC, and NCI-CTC scoring systems., Int. J. Radiat. Oncol. Biol. Phys. 55, 93-98 (2003). 10.1016/S0360-3016(02)03819-1 (Pubitemid 36020347)
5. C. J. Langer, J. Harris, E. M. Horwitz, N. Nicolaou, M. Kies, W. Curran, S. Wong, and K. Ang, Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: Results of Radiation Therapy Oncology Group Protocol 9911., J. Clin. Oncol. 25, 4800-4805 (2007). 10.1200/JCO.2006.07.9194 (Pubitemid 350086484)
6. D. I. Rosenthal, J. S. Lewin, and A. Eisbruch, Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer., J. Clin. Oncol. 24, 2636-2643 (2006). 10.1200/JCO.2006.06.0079 (Pubitemid 46622085)
7. C. Fakhry, W. H. Westra, S. Li, A. Cmelak, J. A. Ridge, H. Pinto, A. Forastiere, and M. L. Gillison, Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial., J. Natl. Cancer. Inst. 100, 261-269 (2008). 10.1093/jnci/djn011 (Pubitemid 351480538)
8. F. P. Worden, B. Kumar, J. S. Lee, G. T. Wolf, K. G. Cordell, J. M. Taylor, S. G. Urba, A. Eisbruch, T. N. Teknos, D. B. Chepeha, M. E. Prince, C. I. Tsien, N. J. D'Silva, K. Yang, D. M. Kurnit, H. L. Mason, T. H. Miller, N. E. Wallace, C. R. Bradford, and T. E. Carey, Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: Response and survival positively associated with HPV16 copy number., J. Clin. Oncol. 26, 3138-3146 (2008). 10.1200/JCO.2007.12.7597
9. R. Hermans, P. Lambin, W. Van den Bogaert, K. Haustermans, A. Van der Goten, and A. L. Baert, Non-invasive tumour perfusion measurement by dynamic CT: Preliminary results., Radiother. Oncol. 44, 159-162 (1997). 10.1016/S0167-8140(97)01913-0 (Pubitemid 27345203)
10. P. J. Hoskin, M. I. Saunders, K. Goodchild, M. E. Powell, N. J. Taylor, and H. Baddeley, Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer., Br. J. Radiol. 72, 1093-1098 (1999).
11. E. Brun, E. Kjellen, J. Tennvall, T. Ohlsson, A. Sandell, R. Perfekt, R. Perfekt, J. Wennerberg, and S. E. Strand, FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma., Head Neck 24, 127-135 (2002). 10.1002/hed.10037 (Pubitemid 34111509)
12. R. Hermans, M. Meijerink, W. Van den Bogaert, A. Rijnders, C. Weltens, and P. Lambin, Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy., Int. J. Radiat. Oncol. Biol. Phys. 57, 1351-1356 (2003). 10.1016/S0360-3016(03)00764- 8 (Pubitemid 37443976)
13. K. Lehtio, O. Eskola, T. Viljanen, V. Oikonen, T. Gronroos, L. Sillanmaki, R. Grenman, and H. Minn, Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer., Int. J. Radiat. Oncol. Biol. Phys. 59, 971-982 (2004). 10.1016/j.ijrobp.2003.12.014 (Pubitemid 38834289)
14. D. Thorwarth, S. M. Eschmann, J. Scheiderbauer, F. Paulsen, and M. Alber, Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer., BMC Cancer 5, 152 (2005). 10.1186/1471-2407-5-152 (Pubitemid 41800127)
15. D. Gandhi, D. B. Chepeha, T. Miller, R. C. Carlos, C. R. Bradford, R. Karamchandani, F. Worden, A. Eisbruch, T. N. Teknos, G. T. Wolf, and S. K. Mukherji, Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy., AJNR Am. J. Neuroradiol. 27, 101-106 (2006). (Pubitemid 46939894)
16. A. Zima, R. Carlos, D. Gandhi, I. Case, T. Teknos, and S. K. Mukherji, Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy, AJNR Am. J. Neuroradiol. 28, 328-334 (2007). (Pubitemid 46281057)
17. Y. Cao, A. Popovtzer, D. Li, D. B. Chepeha, J. S. Moyer, M. E. Prince, F. Worden, T. Teknos, C. Bradford, S. K. Mukherji, and A. Eisbruch, Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: A prospective study., Int. J. Radiat. Oncol. Biol. Phys. 72, 1287-1290 (2008). 10.1016/j.ijrobp.2008.08.024
18. A. Wismuller, A. Meyer-Baese, O. Lange, M. F. Reiser, and G. Leinsinger, Cluster analysis of dynamic cerebral contrast-enhanced perfusion MRI time-series., IEEE Trans. Med. Imaging 25, 62-73 (2006). 10.1109/TMI.2005.861002 (Pubitemid 43172585)
19. S. C. Chen and D. Q. Zhang, Robust image segmentation using FCM with spatial constraints based on new kernel-induced distance measure., IEEE Trans. Syst. Man Cybern., Part B: Cybern. 34, 1907-1916 (2004). 10.1109/TSMCB.2004. 831165
20. P. S. Tofts, G. Brix, D. L. Buckley, J. L. Evelhoch, E. Henderson, M. V. Knopp, H. B. Larsson, T. Y. Lee, N. A. Mayr, G. J. Parker, R. E. Port, J. Taylor, and R. M. Weisskoff, Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: Standardized quantities and symbols., J. Magn. Reson. Imaging 10, 223-232 (1999). 10.1002/(SICI)1522-2586(199909)10:3223::AID-JMRI2>3.0.CO;2-S (Pubitemid 29463104)
21. N. A. Mullani, R. A. Goldstein, K. L. Gould, S. K. Marani, D. J. Fisher, H. A. O'Brien Jr., and M. D. Loberg, Myocardial perfusion with rubidium-82. I. Measurement of extraction fraction and flow with external detectors., J. Nucl. Med. 24, 898-906 (1983). (Pubitemid 14236772)
22. Y. Cao and Z. Shen, Integrated software tools for multi-modality functional images in cancer clinical trials., Med. Phys. 34, 2395-2395 (2007). 10.1118/1.2760622
23. C. Metz, ROCKIT, computer program, version 0.91b, Department of Radiology, The University of Chicago, Chicago, IL, 1998.
24. J. Asaumi, Y. Yanagi, H. Konouchi, M. Hisatomi, H. Matsuzaki, and K. Kishi, Application of dynamic contrast-enhanced MRI to differentiate malignant lymphoma from squamous cell carcinoma in the head and neck., Oral Oncol. 40, 579-584 (2004). 10.1016/j.oraloncology.2003.12.002 (Pubitemid 38452677)
25. S. Kim, H. Quon, L. A. Loevner, M. A. Rosen, L. Dougherty, A. M. Kilger, J. D. Glickson, and H. Poptani, Transcytolemmal water exchange in pharmacokinetic analysis of dynamic contrast-enhanced MRI data in squamous cell carcinoma of the head and neck., J. Magn. Reson. Imaging 26, 1607-1617 (2007). 10.1002/jmri.21207 (Pubitemid 350301150)
26. J. G. Rajendran, D. A. Mankoff, F. O'Sullivan, L. M. Peterson, D. L. Schwartz, E. U. Conrad, A. M. Spence, M. Muzi, D. G. Farwell, and K. A. Krohn, Hypoxia and glucose metabolism in malignant tumors: Evaluation by 18Ffluoromisonidazole and 18Ffluorodeoxyglucose positron emission tomography imaging., Clin. Cancer Res. 10, 2245-2252 (2004). 10.1158/1078-0432.CCR-0688-3 (Pubitemid 38445681)
27. J. G. Rajendran, D. L. Schwartz, J. O'Sullivan, L. M. Peterson, P. Ng, J. Scharnhorst, J. R. Grierson, and K. A. Krohn, Tumor hypoxia imaging with F-18 fluoromisonidazole positron emission tomography in head and neck cancer., Clin. Cancer Res. 12, 5435-5441 (2006). 10.1158/1078-0432.CCR-05-1773 (Pubitemid 44497258)
28. D. Thorwarth, S. M. Eschmann, F. Paulsen, and M. Alber, A model of reoxygenation dynamics of head-and-neck tumors based on serial 18F-fluoromisonidazole positron emission tomography investigations., Int. J. Radiat. Oncol. Biol. Phys. 68, 515-521 (2007). 10.1016/j.ijrobp.2006.12.037 (Pubitemid 46694174)
29. N. Y. Lee, J. G. Mechalakos, S. Nehmeh, Z. Lin, O. D. Squire, S. Cai, K. Chan, P. B. Zanzonico, C. Greco, C. C. Ling, J. L. Humm, and H. Schoder, Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: A feasibility study., Int. J. Radiat. Oncol. Biol. Phys. 70, 2-13 (2008). 10.1016/j.ijrobp.2007.06.039 (Pubitemid 350251039)
30. M. Nordsmark, M. Overgaard, and J. Overgaard, Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck., Radiother. Oncol. 41, 31-39 (1996). 10.1016/S0167-8140(96)91811-3 (Pubitemid 26396294)
31. D. M. Brizel, G. S. Sibley, L. R. Prosnitz, R. L. Scher, and M. W. Dewhirst, Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck., Int. J. Radiat. Oncol. Biol. Phys. 38, 285-289 (1997). 10.1016/S0360-3016(97)00101-6 (Pubitemid 27318643)
32. P. Stadler, A. Becker, H. J. Feldmann, G. Hansgen, J. Dunst, F. Wurschmidt, and M. Molls, Influence of the hypoxic subvolume on the survival of patients with head and neck cancer., Int. J. Radiat. Oncol. Biol. Phys. 44, 749-754 (1999). 10.1016/S0360-3016(99)00115-7 (Pubitemid 29284123)
33. M. Nordsmark, S. M. Bentzen, V. Rudat, D. Brizel, E. Lartigau, P. Stadler, A. Becker, M. Adam, M. Molls, J. Dunst, D. J. Terris, and J. Overgaard, Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study., Radiother. Oncol. 77, 18-24 (2005). 10.1016/j.radonc.2005.06.038 (Pubitemid 41503384)
34. J. A. Bertout, S. A. Patel, and M. C. Simon, The impact of O2 availability on human cancer., Nat. Rev. Cancer 8, 967-975 (2008). 10.1038/nrc2540
35. M. Bruehlmeier, B. Kaser-Hotz, R. Achermann, C. R. Bley, M. Wergin, P. A. Schubiger, and S. M. Ametamey, Measurement of tumor hypoxia in spontaneous canine sarcomas., Vet. Radiol. Ultrasound 46, 348-354 (2005). 10.1111/j.1740-8261.2005.00065.x (Pubitemid 41413580)
36. S. A. Nehmeh, N. Y. Lee, H. Schroder, O. Squire, P. B. Zanzonico, Y. E. Erdi, C. Greco, G. Mageras, H. S. Pham, S. M. Larson, C. C. Ling, and J. L. Humm, Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer., Int. J. Radiat. Oncol. Biol. Phys. 70, 235-242 (2008). 10.1016/j.ijrobp.2007.08.036 (Pubitemid 350251048)
37. H. Cho, E. Ackerstaff, S. Carlin, M. E. Lupu, Y. Wang, A. Rizwan, J. O'Donoghue, C. C. Ling, J. L. Humm, P. B. Zanzonico, and J. A. Koutcher, Noninvasive multimodality imaging of the tumor microenvironment: Registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia., Neoplasia 11, 247-259 (2009). 10.1593/neo.81360
38. J. F. A. Jansen, H. Schöder, N. Y. Lee, Y. Wang, D. G. Pfister, M. G. Fury, H. E. Stambuk, J. L. Humm, J. A. Koutcher, and A. Shukla-Dave, Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases., Int. J. Radiat. Oncol. Biol. Phys. (2009). 10.1016/j.ijrobp.2009.07.009
39. S. C. Barranco, R. R. Perry, M. E. Durm, A. L. Werner, S. G. Gregorcyk, W. E. Bolton, P. Kolm, and C. M. Townsend Jr., Intratumor variability in prognostic indicators may be the cause of conflicting estimates of patient survival and response to therapy., Cancer Res. 54, 5351-5356 (1994). (Pubitemid 24336024)
40. Y. Cao, V. Nagesh, D. Hamstra, C. I. Tsien, B. D. Ross, T. L. Chenevert, L. Junck, and T. S. Lawrence, The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas., Cancer Res. 66, 8912-8917 (2006). 10.1158/0008-5472.CAN-05-4328 (Pubitemid 44449210)
41. Y. Cao, C. I. Tsien, V. Nagesh, L. Junck, R. Ten Haken, B. D. Ross, T. L. Chenevert, and T. S. Lawrence, Clinical investigation survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT., Int. J. Radiat. Oncol. Biol. Phys. 64, 876 (2006). 10.1016/j.ijrobp.2005.09.001
42. E. D. Angelini, J. Atif, J. Delon, E. Mandonnet, H. Duffau, and L. Capelle, Detection of glioma evolution on longitudinal MRI studies., in Proceedings of the 4th IEEE International Symposium on Biomedical Imaging: From Nano to Macro, 2007, Arlington, VA, (unpublished).
43. O. I. Craciunescu, D. S. Yoo, E. Cleland, N. Muradyan, M. D. Carroll, J. R. MacFall, D. P. Barboriak, and D. M. Brizel, Dynamic contrast-enhanced MRI in head-and-neck cancer: The impact of region of interest selection on the intra- and interpatient variability of pharmacokinetic parameters., Int. J. Radiat. Oncol. Biol. Phys. 82, e345-e350 (2012). 10.1016/j.ijrobp.2011.05.059
44. B. A. Moffat, T. L. Chenevert, T. S. Lawrence, C. R. Meyer, T. D. Johnson, Q. Dong, C. Tsien, S. Mukherji, D. J. Quint, S. S. Gebarski, P. L. Robertson, L. R. Junck, A. Rehemtulla, and B. D. Ross, Functional diffusion map: A noninvasive MR1 biomarker for early stratification of clinical brain tumor response., Proc. Natl. Acad. Sci. U.S.A. 102, 5524-5529 (2005). 10.1073/pnas.0501532102 (Pubitemid 40530291)
45. I. J. Simpson, M. W. Woolrich, A. R. Groves, and J. A. Schnabel, Longitudinal brain MRI analysis with uncertain registration., Med. Image Comput. Comput. Assist. Interv. 14, 647-654 (2011).
46. G. Chetelat, B. Landeau, F. Eustache, F. Mezenge, F. Viader, V. de la Sayette, B. Desgranges, and J. C. Baron, Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: A longitudinal MRI study., Neuroimage 27, 934-946 (2005). 10.1016/j.neuroimage.2005.05.015 (Pubitemid 41317262)
47. I. Yanovsky, P. M. Thompson, S. J. Osher, H. Xue, D. W. Shattuck, A. W. Toga, and A. D. Leow, Validating unbiased registration on longitudinal MRI scans from the Alzheimers disease neuroimaging initiative (ADNI)., in Proceedings of the 5th IEEE International Symposium on Biomedical Imaging: From Nano to Macro, 2008, Paris, France, (unpublished).
48. Y. Cao, D. Li, Z. Shen, and D. Normolle, Sensitivity of quantitative metrics derived from DCE MRI and a pharmacokinetic model to image quality and acquisition parameters., Acad. Radiol. 17, 468-478 (2010). 10.1016/j.acra.2009. 10.021
49. M. Mancas and B. Gosselin, Towards an automatic tumor segmentation using iterative watersheds., Proc. SPIE 5370, 1598-1608 (2004).
50. P. Tylsky, G. Bonniaud, E. Decencière, J. Stawiaski, D. Lefkopoulos, and M. Ricard, 18F-FDG PET images segmentation using morphological watershed: A phantom study., in Proceedings of IEEE Nuclear Science Symposium and Medical Imaging Conference, San Diego, CA, 2006.
51. X. Geets, J. A. Lee, A. Bol, M. Lonneux, and V. Gregoire, A gradient-based method for segmenting FDG-PET images: Methodology and validation., Eur. J. Nucl. Med. Mol. Imaging 34, 1427-1438 (2007). 10.1007/s00259-006-0363-4 (Pubitemid 47312577)
52. M. Wanet, J. A. Lee, B. Weynand, M. De Bast, A. Poncelet, V. Lacroix, E. Coche, V. Gregoire, and X. Geets, Gradient-based delineation of the primary GTV on FDG-PET in non-small cell lung cancer: A comparison with threshold-based approaches, CT and surgical specimens., Radiother. Oncol. 98, 117-125 (2010). 10.1016/j.radonc.2010.10.006
53. M. Hatt, F. Lamare, N. Boussion, A. Turzo, C. Collet, F. Salzenstein, C. Roux, P. Jarritt, K. Carson, C. Cheze-Le Rest, and D. Visvikis, Fuzzy hidden Markov chains segmentation for volume determination and quantitation in PET., Phys. Med. Biol. 52, 3467-3491 (2007). 10.1088/0031-9155/52/12/010 (Pubitemid 46830637)
54. M. Hatt, C. Cheze le Rest, A. Turzo, C. Roux, and D. Visvikis, A fuzzy locally adaptive Bayesian segmentation approach for volume determination in PET., IEEE Trans. Med. Imaging 28, 881-893 (2009). 10.1109/TMI.2008.2012036
55. M. Hatt, C. Cheze le Rest, P. Descourt, A. Dekker, D. De Ruysscher, M. Oellers, P. Lambin, O. Pradier, and D. Visvikis, Accurate automatic delineation of heterogeneous functional volumes in positron emission tomography for oncology applications., Int. J. Radiat. Oncol. Biol. Phys. 77, 301-308 (2010). 10.1016/j.ijrobp.2009.08.018